60 Degrees Pharmaceuticals Inc. SXTP

1.17 0.02 1.74% as of 25 Sep
Market cap
$4.1M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
110.82% 146.27% 124.83% 185.35%

+8 more TTM periods

ROA
(186.70%) (118.95%) (132.40%) (115.92%)
ROIC
(348.64%) (352.89%) (771.41%) (2,193.93%)
Return on Tangible Assets
(333.56%) (163.16%) (223.25%) (188.46%)
Average Days of Receivables
170.33 93.21 131.99 180.23
Free Cash Flow per Share
(3.41) (4.78) (10.55) (7.49)
Free Cash Flow
(9.06) (8.25) (7.07) (6.88)
Capital Expenditures
(0.29) (0.25) (0.22) (0.09)
Piotroski F-Score
4.00 3.00 3.00 3.00
Other line items
Cash ROIC
(247.11%) (98.90%) (111.73%) (80.29%)
Accounts Receivable Turnover
2.82 3.19 2.83 2.74
Accounts Payable Turnover
0.65 0.60 0.63 0.95
Inventory Turnover
0.82 0.94 1.42 2.02
Average Days of Payables
646.79 683.76 681.39 514.57
Days of Inventory on Hand
466.15 418.55 306.73 194.91
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
196.19% 153.38% 149.46% 148.46%
Selling, General and Administrative Expense of Revenue
538.56% 490.23% 445.62% 473.80%
Share Based Compensation of Revenue
18.87% 16.49% 19.86% 16.82%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
1.11 1.05 0.93 0.83
Depreciation/Fixed assets
1.18 1.04 1.05 1.10
Capex/Depreciation
(1.00) (0.94) (0.84) (0.35)
Revenue per Share
0.46 0.76 2.10 1.49
Operating CF per Share
(3.31) (4.63) (10.22) (7.40)
Capex per Share
(0.11) (0.15) (0.33) (0.10)
Capex to Sales
0.24 0.19 0.15 0.06
Net Profit Margin
(650.34%) (576.26%) (522.64%) (599.16%)

Fold the line items

Columns are period end dates